Leveraging Extracellular Non-coding RNAs to Diagnose and Treat Heart Diseases

J Cardiovasc Transl Res. 2022 Jun;15(3):456-468. doi: 10.1007/s12265-022-10252-x. Epub 2022 Apr 13.

Abstract

Extracellular vesicles (EVs), including exosomes and microvesicles, emerge to be crucial mediators of cell-to-cell communication in multiple organs. Non-coding RNAs loaded inside EVs contribute as one major mechanism for remote information transfer among different cell types or organs. Increasing evidence suggests that EV-associated non-coding RNAs derived from cardiovascular or non-cardiac cells regulate cardiovascular pathophysiology in heart development and diseases. The functional relevance of the EV-associated ncRNAs in heart diseases provides an avenue to develop novel diagnostic tools and therapies for heart diseases. In this review, we summarize the recent advancement of EV-associated ncRNAs in different cardiovascular diseases, including myocardial infarction, arrhythmias, cardiac hypertrophy, and heart failure, with an emphasis on the underlying molecular mechanisms.

Keywords: Cardiovascular diseases; Cell-to-cell communication; Extracellular vesicles; Non-coding RNAs.

Publication types

  • Review

MeSH terms

  • Biomarkers / metabolism
  • Cardiomegaly / metabolism
  • Extracellular Vesicles* / genetics
  • Extracellular Vesicles* / metabolism
  • Humans
  • Myocardial Infarction* / metabolism
  • RNA, Untranslated / genetics
  • RNA, Untranslated / metabolism

Substances

  • Biomarkers
  • RNA, Untranslated